Automation & Robotics

#Artificial intelligence (AI) #Automation / robotics #Collaboration #Drug discovery #Pierre Fabre #XtalPi

Pierre Fabre and XtalPi team up on drug discovery

Pharmaceutical company Laboratoires Pierre Fabre and AI platform company XtalPi have announced a collaboration to discover novel drug candidates across oncology, rare diseases, and dermatology.  Under the agreement, XtalPi will use its integrated AI capabilities and robotics platform to de novo design and deliver novel small molecule… Read More

#Business & Investment #News

#Artificial intelligence (AI) #Automation / robotics #Financing #Opentrons

Opentrons announces $40m Series E funding round

Opentrons Labworks has announced a $40 million Series E financing led by healthcare investor Avego, with additional investment from BroadOak Capital Partners.   Opentrons says it will use the capital to scale its robotics, software, and data infrastructure tools.  While AI is transforming how science is… Read More

#Business & Investment #News

#Artificial intelligence (AI) #Automation #Benchling #Drug discovery #Webinar

Last chance to register: How AI agents are accelerating R&D

R&D teams don’t need another chatbot. They need a team that can act on their behalf, guided by the scientists who know the science best. The future of R&D removes the toil of day-to-day work and connects the data scattered across your systems and teams. In this webinar, taking place… Read More

#News

#Artificial intelligence (AI) #Automation #Benchling #Drug discovery #Webinar

Webinar: How AI agents are accelerating R&D

R&D teams don’t need another chatbot. They need a team that can act on their behalf, guided by the scientists who know the science best. The future of R&D removes the toil of day-to-day work and connects the data scattered across your systems and teams. In this webinar, taking place… Read More

#News

Artificial intelligence
#Artificial intelligence (AI) #Automation #Benchling #Drug discovery #Webinar

Webinar presents your infinite program team with AI

R&D teams don’t need another chatbot. They need a team that can act on their behalf, guided by the scientists who know the science best. The future of R&D removes the toil of day-to-day work and connects the data scattered across your systems and teams. In this webinar, taking place… Read More

#News

#Artificial intelligence (AI) #Automation #Benchling #Drug discovery #Webinar

Webinar explores how AI agents are accelerating R&D

R&D teams don’t need another chatbot. They need a team that can act on their behalf, guided by the scientists who know the science best. The future of R&D removes the toil of day-to-day work and connects the data scattered across your systems and teams. In this webinar, taking place… Read More

#News

#Automation / robotics #Drug discovery #iiCON: Infection Innovation Consortium #Infectious diseases #Lab automation

How iiCON is accelerating global infectious disease R&D

iiCON at the heart of infectious disease research   This year, a new AI robotic laboratory designed to accelerate the discovery of drugs and vaccines for infectious diseases was announced in Liverpool UK.   The £20 million ($26.4 million) Liverpool Accelerate Laboratory was developed through the Infection Innovation Consortium: iiCON – an initiative dedicated… Read More

#Exclusive Content

#Artificial intelligence (AI) #Automation #Benchling #Drug discovery #Webinar

New webinar – Your infinite program team: How AI agents are accelerating R&D

R&D teams don’t need another chatbot. They need a team that can act on their behalf, guided by the scientists who know the science best. The future of R&D removes the toil of day-to-day work and connects the data scattered across your systems and teams. In this webinar, taking place… Read More

#News

Molecular,Model,Of,Antibody
#Antibody engineering #Automation / robotics #Drug development #Generative AI

Antibody engineering after generative AI: Solving the validation bottleneck

Stacey Willard, Vice President of Marketing and Product Management at Nuclera, explores the validation bottleneck for antibody engineering and why generative AI may be the answer to this challenge.  Antibody engineering has developed a pronounced asymmetry. AI can now generate and rank antibody candidates at a pace that conventional experimental… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Drug discovery #Infectious diseases #Lab automation #Organoids #UK

New robotic AI lab opens in Liverpool to help fight infectious diseases  

The UK’s first high-security robotic AI laboratory designed to accelerate the discovery of drugs and vaccines for infectious diseases has opened in Liverpool.   The £20 million Liverpool Accelerate Laboratory has been developed through the Infection Innovation Consortium: iiCON, which advances pioneering infection R&D through collaboration between industry, researchers and the NHS. It… Read More

#News

#Automation #Chromatography #Drug discovery #Purification technology #Webinar

Last chance to register: Rethinking protein purification

Join this webinar, hosted by DDW and supported by Cytiva, to learn how automation, parallel chromatography, and smart software features can help scientists increase throughput, reduce hands-on time, and maintain consistent purification performance. Join for free on Tuesday, September 15 to learn: How parallel chromatography can be used to process… Read More

#News

#Automation #Chromatography #Drug discovery #Purification technology #Webinar

Upcoming webinar rethinks protein purification

Join this webinar, hosted by DDW and supported by Cytiva, to learn how automation, parallel chromatography, and smart software features can help scientists increase throughput, reduce hands-on time, and maintain consistent purification performance. Join for free on Tuesday, September 15 to learn: How parallel chromatography can be used to process… Read More

#News

#Automation #Chromatography #Drug discovery #Webinar

How to increase throughput with chromatography & automation

Join this webinar, “Rethinking protein purification: How to increase throughput with parallel chromatography and automation”, hosted by DDW and supported by Cytiva, to learn how automation, parallel chromatography, and smart software features can help scientists increase throughput, reduce hands-on time, and maintain consistent purification performance. Join for free on… Read More

#News

#Automation #Chromatography #Drug discovery #Purification technology #Webinar

Register now: Webinar on rethinking protein purification

Join this webinar, hosted by DDW and supported by Cytiva to learn how automation, parallel chromatography, and smart software features can help scientists increase throughput, reduce hands-on time, and maintain consistent purification performance. Join for free on Tuesday, September 15 to learn: How parallel chromatography can be used to process… Read More

#News

Technology in the lab
#Automation #Automation / robotics #Drug discovery #eBook #Lab technology

eBook – The orchestrated lab: From automation to intelligent workflow management

Laboratory automation has been one of the most significant developments in laboratory sciences in recent years, enhancing process quality, eliminating human error and variability, and ultimately making operations more cost-effective and efficient. However, as automation tools become more advanced and complex, this can create connectivity issues and disrupt existing workflows, potentially preventing seamless connection with… Read More

#News

#Automation #Automation / robotics #Drug discovery #Lab technology #Webinar

Last chance to register: Moving beyond siloed automation in an orchestrated lab

Many laboratories have invested in automation, yet workflows often remain fragmented, with disconnected instruments, data, and processes creating inefficiencies and limiting scalability. As scientific workflows grow more complex, automation alone is no longer enough. Leading labs are now embracing orchestration, the coordination of instruments, robotics, software, data, and people across… Read More

#News